Mao Huang

Title: Innovations by Mao Huang in Opioid Analgesics

Introduction

Mao Huang is a notable inventor based in Beijing, China. He has made significant contributions to the field of opioid analgesics, focusing on methods to identify low or non-addictive options. His work aims to address the pressing issue of opioid addiction while providing effective pain relief.

Latest Patents

Mao Huang holds two patents, both centered around the identification of low or non-addictive opioid analgesics. His latest patents include a method that utilizes a bioassay combining an electrophysiological method and a cell culture system of dorsal-root ganglion (DRG) neurons. This innovative approach screens and identifies opioids with a high potential for use as low- or non-addictive analgesics. Additionally, his patents highlight a specific group of opioid alkaloids and their analogues, which uniquely activate only inhibitory opioid receptor functions, thus minimizing the risk of addiction. Notably, the patents also emphasize the specific use of etorphine or dihydroetorphine from the opioid alkaloid family as potential low- or non-addictive analgesics and for treating opioid addiction.

Career Highlights

Mao Huang is currently associated with United Biomedical, Inc., where he continues to advance his research in opioid analgesics. His work is pivotal in the ongoing efforts to develop safer pain management solutions.

Collaborations

Mao Huang collaborates with esteemed colleagues, including Bo-yi Qin and Xiong-qi Gong, who contribute to his research endeavors.

Conclusion

Mao Huang's innovative work in identifying low or non-addictive opioid analgesics represents a significant advancement in pain management and addiction treatment. His contributions are vital in addressing the challenges posed by opioid use and addiction.